The findings from this part of the study indicate that after further increasing the number of samples included in the research, EIF3M exhibited significantly higher expression levels in tumor tissues compared to normal tissues across the following cancer types: CHOL, COAD, DLBC, GBM, LGG, LIHC, PAAD, READ, TGCT, and THYM. The gene discussed is EIF3M; the disease is neoplasm.